Cellulitis and erysipelas: Clinical sciences

1,471views

00:00 / 00:00

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

A 71-year-old man presents to his primary care physician for evaluation of a painful rash over his right lower calf for the past four days. The patient reports that he has otherwise been feeling well, and has not had fevers or chills. Past medical history includes hypertension and obesity. Temperature is 37°C (98.6°F), blood pressure is 140/70 mmHg, pulse is 77/min, respiratory rate is 13/min, and oxygen saturation is 98% on room air. On physical examination, the patient has an area of warmth and tenderness over the right lower extremity without well-demarcated borders. The patient is prescribed oral cephalexin. 48 hours later, he was reassessed and found to have minimal improvement in the physical exam. Repeat vital signs are within normal limits. Which of the following is the best next step in management?  

Transcript

Watch video only

Cellulitis and erysipelas are acute infections of the skin and subcutaneous tissues. Erysipelas is an infection of the upper layer of the dermis with the superficial lymphatics and vessels, while cellulitis affects the deeper layers of the dermis and the subdermal tissues. These infections usually occur when bacteria enter through breaks in the skin barrier, such as a laceration and puncture wound. The vast majority of infections are caused by beta-hemolytic Streptococci, such as Group A Streptococcus or Streptococcus pyogenes; as well as Staphylococcus aureus including methicillin-resistant or MRSA. While erysipelas is usually limited to the skin, cellulitis can sometimes present with or without systemic symptoms.

When approaching an individual with signs and symptoms suggestive of cellulitis and erysipelas, first obtain a focused history and physical examination. Alright, let’s start with erysipelas. On history, the patient might report an acute onset of skin redness, swelling, and pain usually around the face or the extremities. Notably, there won’t be systemic symptoms like fever and chills, and this is one of the main factors distinguishing erysipelas from cellulitis. A physical exam typically reveals a well-demarcated area of erythema with superficial induration that is warm and tender to touch.

Because erysipelas is a local infection, you can start the patient on oral antibiotics such as a penicillin or first-generation cephalosporin. Then, assess the response at 24 to 48 hours. If the patient shows adequate response, in other words, erythema, induration, and pain have improved, they can continue the current treatment and complete the course of antibiotics. However, if the patient has an inadequate response, assess for signs of spreading infection or abscess and consider switching the antibiotics to broaden the coverage.

Alright, now that patients with erysipelas are treated, let’s go back to history and physical and talk about patients with more severe signs of infection. Similar to erysipelas, the patient might report skin redness, swelling, and pain over the affected area. However, they may or may not present with systemic symptoms, such as fevers or chills.

On physical exam, the area of erythema is typically not well-demarcated, and induration might not always be present. Additionally, you can expect the erythematous area to feel warm to the touch or tender on palpation. If you see these findings, you should suspect cellulitis. The next step is to assess for systemic signs and symptoms. If the patient does not have either of those features, they have cellulitis without systemic symptoms.

Sources

  1. "Interventions for the prevention of recurrent erysipelas and cellulitis" Cochrane Database Syst Rev (2017)
  2. "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America" Clin Infect Dis (2014)
  3. "Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors" Clin Infect Dis (2016)
  4. "Route and duration of antibiotic therapy in acute cellulitis: A systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment" J Infect (2020)
  5. "National Trends in Incidence of Purulent Skin and Soft Tissue Infections in Patients Presenting to Ambulatory and Emergency Department Settings, 2000-2015" Clin Infect Dis (2020)
  6. "Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary" Clin Infect Dis (2011)
  7. "Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010" BMC Infect Dis (2015)
  8. "Cellulitis: A Review" JAMA (2016)
  9. "Cellulitis" N Engl J Med (2004)
  10. "Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality " Crit Care Med (2011)